|
An investment in knowledge pays the best interest
-- Benjamin Franklin 1706-1790
In 2002, NTSAD launched its Research Initiative with the goals of focusing and accelerating research through a network of scientists, clinicians, and patient organizations. Over that time, we have funded a number of projects that populate a research roadmap spanning research/proof of science and animal trials. Some of these seed projects have also led to follow-on government funding to help us move toward clinical trials and to commercially available therapies.
NTSAD is soliciting proposals for innovative research projects that would generate strong preliminary data for major funding in the area of neurodegenerative disorders affecting the CNS , especially lysosomal storage disorders and pediatric leukodystrophies (such as Canavan and Krabbe). Projects can be basic or translational and can build off of previous work with such areas as neural stem cells, the blood brain barrier, molecular chaperones, gene therapy, and substrate inhibitors as well as exploring other novel therapeutic strategies. The funders are especially interested in projects that bridge potential treatment of LSDs and leukodystrophies of the CNS . Funding would be $30,000 to $45,000 for one year, inclusive of indirect costs not to exceed 10%. The deadline for proposals is 5:00 p.m. (EST), Friday, February 29, 2008 .
Click here for complete applications guidelines.
|
|